Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


30.12.2024

1 Ann Surg Oncol
1 BMC Cancer
2 Breast Cancer
3 Breast Cancer (Dove Med Press)
2 Breast Cancer Res Treat
1 Cancer Chemother Pharmacol
1 Cancer Lett
10 Clin Breast Cancer
2 Eur J Surg Oncol
1 Gene
1 Int J Cancer
1 Lancet Oncol
1 Nature
4 PLoS One
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. CHO MJ, Senger JL, Park KU, Hansotia K, et al
    Preventing Breast Cancer-Related Lymphedema: A Comprehensive Analysis of a 9-Year Single-Center Experience of Prophylactic Lymphovenous Bypass.
    Ann Surg Oncol. 2024 Dec 23. doi: 10.1245/s10434-024-16640.
    PubMed         Abstract available


    BMC Cancer

  2. CHEN Y, He J, Song T, Zhang Y, et al
    Comparing supraclavicular surgery with radiotherapy versus radiotherapy alone in breast cancer patients with ipsilateral supraclavicular lymph node metastasis: a two-center retrospective cohort study.
    BMC Cancer. 2024;24:1572.
    PubMed         Abstract available


    Breast Cancer

  3. LIU P, Liu D, Zhao C, Wei Y, et al
    Identifying subgroups of ypN1 breast cancer patients who may exempt from axillary lymph node dissection after neoadjuvant chemotherapy: insights from a large cohort study.
    Breast Cancer. 2024 Dec 27. doi: 10.1007/s12282-024-01663.
    PubMed         Abstract available

  4. USHIGUSA T, Hirakawa N, Kajiura Y, Yoshida A, et al
    Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study.
    Breast Cancer. 2024 Dec 27. doi: 10.1007/s12282-024-01662.
    PubMed         Abstract available


    Breast Cancer (Dove Med Press)

  5. MENG S, Cao Y, Lu L, Li X, et al
    Quercetin Promote the Chemosensitivity in Organoids Derived from Patients with Breast Cancer.
    Breast Cancer (Dove Med Press). 2024;16:993-1004.
    PubMed         Abstract available

  6. GUO Y, Liao J, Li S, Shang Y, et al
    Preoperative Prediction of Breast Cancer Histological Grade Using Intratumoral and Peritumoral Radiomics Features from T2WI and DWI MR Sequences.
    Breast Cancer (Dove Med Press). 2024;16:981-991.
    PubMed         Abstract available

  7. GUMP FE, Parmar P, Feldman S, Gupta AM, et al
    The History of Breast Cancer Early Detection: 1865 - 2020.
    Breast Cancer (Dove Med Press). 2024;16:973-980.
    PubMed         Abstract available


    Breast Cancer Res Treat

  8. FALTINOVA M, Vehmanen L, Lyytinen H, Savolainen-Peltonen H, et al
    Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial.
    Breast Cancer Res Treat. 2024 Dec 27. doi: 10.1007/s10549-024-07564.
    PubMed         Abstract available

  9. MALON D, Molto C, Prasla S, Cuthbert D, et al
    Steatotic liver disease in metastatic breast cancer treated with endocrine therapy and CDK4/6 inhibitor.
    Breast Cancer Res Treat. 2024 Dec 25. doi: 10.1007/s10549-024-07578.
    PubMed         Abstract available


    Cancer Chemother Pharmacol

  10. ALANDAG C, Ozturk A, Yulak F, Sahin Inan ZD, et al
    HER-2 SMASH.
    Cancer Chemother Pharmacol. 2024;95:10.
    PubMed         Abstract available


    Cancer Lett

  11. WANG K, He Q, Jiang X, Wang T, et al
    Targeting UBE2T suppresses breast cancer stemness through CBX6-mediated transcriptional repression of SOX2 and NANOG.
    Cancer Lett. 2024 Dec 21:217409. doi: 10.1016/j.canlet.2024.217409.
    PubMed         Abstract available


    Clin Breast Cancer

  12. TAO X, Han J, Li Y, Tian Y, et al
    The Difference of RCB 0 and RCB I in Prognosis of Breast Cancer After Neoadjuvant Therapy: A Meta-Analysis.
    Clin Breast Cancer. 2024 Dec 9:S1526-8209(24)00336.
    PubMed         Abstract available

  13. XIONG W, Sun J, Gu Q, Xu T, et al
    Pyrotinib Plus Taxanes or Vinorelbine for the Treatment of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Prospective Evaluation of Efficacy and Safety.
    Clin Breast Cancer. 2024 Dec 5:S1526-8209(24)00355.
    PubMed         Abstract available

  14. NEUMAN HB, Wilke LG, Bozzuto LM, Stelle L, et al
    Engaging Multidisciplinary Teams to Develop Pragmatic Clinical Practice Guidelines to Support Management of Patients With High-Risk Breast Lesions.
    Clin Breast Cancer. 2025;25:56-64.
    PubMed         Abstract available

  15. LI AC, Hammond S, Crosby D, Li Z, et al
    Clinicopathologic Features and Digital Imaging Analysis of HER2 Protein in Breast Carcinomas With Different HER2 Fluorescence in Situ Hybridization Patterns.
    Clin Breast Cancer. 2025;25:38-45.
    PubMed         Abstract available

  16. YAO Y, Zhao Y, Guo X, Xu X, et al
    Deep Learning for Distinguishing Mucinous Breast Carcinoma From Fibroadenoma on Ultrasound.
    Clin Breast Cancer. 2025;25:75-84.
    PubMed         Abstract available

  17. CRUZ HSS, Verdial FC, Shanno JN, Webster AJ, et al
    Axillary Recurrence in Sentinel Lymph Node Negative Mastectomy Patients at 16 Years Median Follow Up: Natural History in the Absence of Radiation.
    Clin Breast Cancer. 2025;25:e63-e70.
    PubMed         Abstract available

  18. CINISELLI CM, Verderio P, Baili P, Sant M, et al
    Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast.
    Clin Breast Cancer. 2025;25:e79-e85.
    PubMed         Abstract available

  19. BHARDWAJ S, Jaffer S
    A Comparative Analysis of the Value of HER2 Immunohistochemistry Scoring in Primary and Metastatic Breast Cancer, in the Era of HER2 "Low" Breast Cancers.
    Clin Breast Cancer. 2024 Dec 4:S1526-8209(24)00331.
    PubMed         Abstract available

  20. PLEASANT VA, Merajver SD
    Universal Genetic Counseling and Testing for Black Women: A Risk-Stratified Approach to Addressing Breast Cancer Disparities.
    Clin Breast Cancer. 2024 Dec 4:S1526-8209(24)00338.
    PubMed         Abstract available

  21. ROSALES-REYNOSO MA, Juarez-Vazquez CI, Garcia-Sanchez IN, Palacios-Ramirez A, et al
    Investigation of HOTAIR rs12826786, rs920778 and rs4759314 Variants With Breast Cancer Susceptibility and Clinicopathological Characteristics in a Mexican Population.
    Clin Breast Cancer. 2024 Dec 3:S1526-8209(24)00335.
    PubMed         Abstract available


    Eur J Surg Oncol

  22. BOUZIANE J, Loap P, Cao K, Pauly L, et al
    Evolution of breast cancer management after mediastinal hodgkin lymphoma: Towards a breast- conserving approach.
    Eur J Surg Oncol. 2024;51:109555.
    PubMed         Abstract available

  23. AIN Q, O'Connell RL, Swarnkar P, McVeigh T, et al
    Breast cancer outcomes in women with ovarian cancer and a pathogenic germline BRCA mutation.
    Eur J Surg Oncol. 2024;51:109380.
    PubMed         Abstract available


    Gene

  24. WANG Y, Zhang J, Wang Y, Liu Y, et al
    Lower expression of MMP2, FLNA, and CFL1 is correlated with favorable prognosis in invasive micropapillary breast cancer.
    Gene. 2024 Dec 24:149192. doi: 10.1016/j.gene.2024.149192.
    PubMed         Abstract available


    Int J Cancer

  25. KOUVARAKI M, Zerdes I, Sifakis EG, Sarafidis M, et al
    Prognostic and predictive implications of sterile alpha motif and HD domain-containing protein 1 (SAMHD1) expression in breast cancer.
    Int J Cancer. 2024 Dec 27. doi: 10.1002/ijc.35319.
    PubMed         Abstract available


    Lancet Oncol

  26. GRUBER K
    Pesticide exposure and increased risk of breast cancer for women in rural Brazil.
    Lancet Oncol. 2024 Dec 19:S1470-2045(24)00726.
    PubMed        


    Nature

  27. BORNES L, van Winden LJ, Geurts VCM, de Bruijn B, et al
    The oestrous cycle stage affects mammary tumour sensitivity to chemotherapy.
    Nature. 2025;637:195-204.
    PubMed         Abstract available


    PLoS One

  28. FANG Q, Fang Q, Cheng R, Feng T, et al
    CAPE activates AMPK and Foxo3 signaling to induce growth inhibition and ferroptosis in triple-negative breast cancer.
    PLoS One. 2024;19:e0315037.
    PubMed         Abstract available

  29. LEMMA SEIFU B, Mekuria Negussie Y, Abrham Asnake A, Daba Chinkey F, et al
    Determinants of breast cancer screening among women of reproductive age in sub-Saharan Africa: A multilevel analysis.
    PLoS One. 2024;19:e0312831.
    PubMed         Abstract available

  30. AMER NN, Khairat R, Hammad AM, Kamel MM, et al
    Correction: DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer.
    PLoS One. 2024;19:e0316591.
    PubMed         Abstract available

  31. ZHANG W, Huang Y, Zhou Y, Xue J, et al
    Delving into female breast cancer: Distinct disease-specific survival outcomes between invasive lobular and ductal carcinomas revealed by propensity score matching.
    PLoS One. 2024;19:e0300116.
    PubMed         Abstract available


    Radiother Oncol

  32. REFSGAARD L, Holm Milo ML, Buhl ES, Jensen JM, et al
    The effect of coronary artery calcifications and radiotherapy on the risk of coronary artery disease in high-risk breast cancer patients in the DBCG RT-Nation cohort.
    Radiother Oncol. 2024 Dec 24:110705. doi: 10.1016/j.radonc.2024.110705.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.